Wed, October 6, 2010
Tue, October 5, 2010
Mon, October 4, 2010
Sun, October 3, 2010
Fri, October 1, 2010
Thu, September 30, 2010
Wed, September 29, 2010
Tue, September 28, 2010
Mon, September 27, 2010
[ Mon, Sep 27th 2010 ] - Market Wire
Wellstar Announces New Website
Sun, September 26, 2010
Sat, September 25, 2010
Fri, September 24, 2010
Thu, September 23, 2010
Wed, September 22, 2010
Tue, September 21, 2010
Mon, September 20, 2010
Fri, September 17, 2010
Thu, September 16, 2010
Wed, September 15, 2010
Tue, September 14, 2010
Mon, September 13, 2010

PPD Announces Third Quarter 2010 Earnings Release, Webcast and Conference Call


//health-fitness.news-articles.net/content/2010/ .. arnings-release-webcast-and-conference-call.html
Published in Health and Fitness on Thursday, September 23rd 2010 at 13:15 GMT by Market Wire   Print publication without navigation


WILMINGTON, N.C.--([ BUSINESS WIRE ])--PPD, Inc. (Nasdaq: PPDI) will release its third quarter 2010 financial results on Tuesday, October 26, 2010, after the market closes. The earnings release will be available on the PPD website at [ www.ppdi.com ].

On Wednesday, October 27, 2010, at 9 a.m. ET, PPD will conduct a live conference call and audio webcast to discuss financial results and the overall business environment. A Q&A session will follow. The conference call will be broadcast live over the Internet and will also be available using the following direct dial numbers:

Participant dial-in: +1 877 644 0692 (U.S./Canada)
+1 973 200 3387 (International)
Conference ID: 83838111

All interested parties can access the webcast through the Presentations & Events link in the Investors section of the PPD Web site at [ www.ppdi.com ]. The webcast will be archived shortly after the call for on-demand replay.

PPD is a leading global contract research organization, celebrating 25 years of providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 42 countries and more than 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit [ www.ppdi.com ].


Publication Contributing Sources